InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
83.05
(
0.24%
)
Bitcoin
67,765.92
(
-2.34%
)
Post# of 251945
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119693
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 200993

Thursday, 04/28/2016 11:02:16 AM

Thursday, April 28, 2016 11:02:16 AM

Post# of 251945
Viekira-Pak Sales by Fiscal† Quarter ($ M)* 
          ---TOTAL--  ----US----  --Ex-US‡-- 
 Quarter  Sales QoQ%  Sales QoQ%  Sales QoQ% 
  
 FY2Q16    414 -26%    125 -37%    289 -19% 
 FY1Q16    554 +18%    197 -19%    357 +57% 
 FY4Q15    469 +21%    242  +7%    227 +44% 
 FY3Q15    385 +67%    227 +64%    158 +70% 
 FY2Q15    231  --     138  --      93  --

†ENTA’s fiscal year ends Sep 30 (e.g. FY2Q16 = calendar 1Q16).

‡Japan sales commenced during FY2Q16.

*Including Viekirax/Technivie 2-DAA regimens.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up